Ted Skolarus, MD, MPH, FACS, is a urologic oncologist who specializes in the care of patients with prostate cancer, including caring for men with elevated prostate-specific antigen (PSA) levels and performing transperineal prostate biopsy.

Dr. Skolarus has fellowship training in urologic oncology, health services research and implementation science. His research aims to better understand and improve the care of men with prostate cancer.

With over 175 publications, Dr. Skolarus has expertise in quantitative and qualitative health services research, clinical trials and state-of-the-art implementation science methods to optimize best practice implementation in real-world clinical settings. In other words, he studies issues of cost, quality, and access to healthcare, and strategies to help get patients the right care in the right place at the right time.

Dr. Skolarus has presented at numerous regional, national and international meetings and organizations. He serves as faculty in the National Cancer Institute’s Training Institute for Dissemination and Implementation Research in Cancer, as well as a reviewer for the NIH Center for Scientific Review. His research has been funded by the National Cancer Institute, VA Health Services Research and Development Service (HSR&D), American Cancer Society, and the American Urological Association.